{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T06:40:26Z","timestamp":1775544026117,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82305163"],"award-info":[{"award-number":["82305163"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>HuoXue QianYang QuTan Recipe (HQQR) is an effective prescription for the clinical management of myocardial hypertrophy in patients with obesity-related hypertension (OBH). In previous studies, HQQR showed the pharmacological properties of mitochondrial protection, anti-inflammatory, and anti-oxidant in OBH rats, which were closely related to its cardioprotective effects. This study is designed to further explore the molecular mechanisms by which HQQR attenuates myocardial hypertrophy in OBH rats.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>High-fat diet-fed SHR were gavaged with HQQR (5\u00a0ml\/kg or 10\u00a0ml\/kg, 3.87\u00a0g\/ml of original drug) or Valsartan (10\u00a0ml\/kg, 3\u00a0mg\/ml of original drug) for 10 weeks. In vitro, the H9C2 cells were stimulated with angiotensin-II (Ang-II) and (or) free fatty acid (FFA) in the absence or presence of HQQR. The effects of HQQR on lipid metabolism, mitochondrial function, glycolysis, pyruvate-lactate axis, and myocardial hypertrophy were examined by immunoblotting, pathological analysis, WGA, oil red O and colorimetric methods. Next, to further explore how HQQR attenuates myocardial hypertrophy, we transfected MPC1 siRNA or MCT4 siRNA into H9C2 cells. Finally, the lactate-stimulated H9C2 cells were treated with HQQR and (or) VB124 (a lactate transporter inhibitor), and the degree of myocardial hypertrophy was evaluated by immunoblotting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared to SHR rats, OBH rats exhibited more pronounced blood pressure, lipid metabolism disorder and myocardial pathology injury, which was attenuated by HQQR treatment. Furthermore, HQQR significantly improved the mitochondrial function, glycolysis, and pyruvate-lactate metabolic axis in OBH rats and Ang-II\u2009+\u2009FFA-treated H9C2 cells, thereby attenuating myocardial hypertrophy. However, these protective effects of HQQR were attenuated in H9C2 cells transfected with MPC1 siRNA and enhanced in cells transfected with MCT4 siRNA. Next, we found that HQQR dose-dependently inhibited the expression \u03b2-MHC and ANP proteins in lactate-stimulated H9C2 cells, and that this effect was further enhanced by combination with VB124.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>HQQR inhibits glycolysis and restores pyruvate-lactate metabolism in OBH rats by regulating MPC1\/MCT4, thereby attenuating myocardial hypertrophy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13020-025-01240-9","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T09:51:44Z","timestamp":1761213104000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["HuoXue QianYang QuTan recipe attenuates myocardial hypertrophy in obese hypertensive rats by regulating MPC1\/MCT4 mediated pyruvate-lactate metabolic axis"],"prefix":"10.1186","volume":"20","author":[{"given":"Jing","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deyu","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"issue":"8","key":"1240_CR1","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41569-022-00829-z","volume":"20","author":"JG Wang","year":"2023","unstructured":"Wang JG, Zhang W, Li Y, Liu L. Hypertension in China: epidemiology and treatment initiatives. Nat Rev Cardiol. 2023;20(8):531\u201345.","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"1240_CR2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","volume":"16","author":"KT Mills","year":"2020","unstructured":"Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16(4):223\u201337.","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"1240_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11906-020-1017-9","volume":"22","author":"CC Nwabuo","year":"2020","unstructured":"Nwabuo CC, Vasan RS. Pathophysiology of hypertensive heart disease: beyond left ventricular hypertrophy. Curr Hypertens Rep. 2020;22(2):11.","journal-title":"Curr Hypertens Rep"},{"issue":"4","key":"1240_CR4","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s00467-020-04579-3","volume":"36","author":"M Litwin","year":"2021","unstructured":"Litwin M, Ku\u0142aga Z. Obesity, metabolic syndrome, and primary hypertension. Pediatr Nephrol. 2021;36(4):825\u201337.","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"1240_CR5","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/HCO.0000000000000868","volume":"36","author":"A daSilva-deAbreu","year":"2021","unstructured":"daSilva-deAbreu A, Alhafez BA, Lavie CJ, Milani RV, Ventura HO. Interactions of hypertension, obesity, left ventricular hypertrophy, and heart failure. Curr Opin Cardiol. 2021;36(4):453\u201360.","journal-title":"Curr Opin Cardiol"},{"issue":"12","key":"1240_CR6","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/s41569-023-00887-x","volume":"20","author":"J Ritterhoff","year":"2023","unstructured":"Ritterhoff J, Tian R. Metabolic mechanisms in physiological and pathological cardiac hypertrophy: new paradigms and challenges. Nat Rev Cardiol. 2023;20(12):812\u201329.","journal-title":"Nat Rev Cardiol"},{"issue":"5","key":"1240_CR7","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/s44161-022-00057-1","volume":"1","author":"W Wang","year":"2022","unstructured":"Wang W, Wang J, Yao K, Wang S, Nie M, Zhao Y, et al. Metabolic characterization of hypertrophic cardiomyopathy in human heart. Nat Cardiovasc Res. 2022;1(5):445\u201361.","journal-title":"Nat Cardiovasc Res"},{"issue":"6","key":"1240_CR8","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jacbts.2016.06.009","volume":"1","author":"NA Diakos","year":"2016","unstructured":"Diakos NA, Navankasattusas S, Abel ED, Rutter J, McCreath L, Ferrin P, et al. Evidence of glycolysis up-regulation and pyruvate mitochondrial oxidation mismatch during mechanical unloading of the failing human heart: implications for cardiac reloading and conditioning. JACC Basic Transl Sci. 2016;1(6):432\u201344.","journal-title":"JACC Basic Transl Sci"},{"issue":"4","key":"1240_CR9","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1161\/CIRCHEARTFAILURE.114.001151","volume":"7","author":"BE Sansbury","year":"2014","unstructured":"Sansbury BE, DeMartino AM, Xie Z, Brooks AC, Brainard RE, Watson LJ, et al. Metabolomic analysis of pressure-overloaded and infarcted mouse hearts. Circ Heart Fail. 2014;7(4):634\u201342.","journal-title":"Circ Heart Fail"},{"issue":"12","key":"1240_CR10","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/s41419-022-05516-y","volume":"13","author":"J Ni","year":"2022","unstructured":"Ni J, Zhang H, Wang X, Liu Z, Nie T, Li L, et al. Rg3 regulates myocardial pyruvate metabolism via P300-mediated dihydrolipoamide dehydrogenase 2-hydroxyisobutyrylation in TAC-induced cardiac hypertrophy. Cell Death Dis. 2022;13(12):1073.","journal-title":"Cell Death Dis"},{"issue":"1","key":"1240_CR11","doi-asserted-by":"publisher","first-page":"E33","DOI":"10.1152\/ajpendo.00074.2022","volume":"323","author":"NKH Yiew","year":"2022","unstructured":"Yiew NKH, Finck BN. The mitochondrial pyruvate carrier at the crossroads of intermediary metabolism. Am J Physiol Endocrinol Metab. 2022;323(1):E33\u201352.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"8061","key":"1240_CR12","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/s41586-025-08667-y","volume":"641","author":"Z He","year":"2025","unstructured":"He Z, Zhang J, Xu Y, Fine EJ, Suomivuori CM, Dror RO, et al. Structure of mitochondrial pyruvate carrier and its inhibition mechanism. Nature. 2025;641(8061):250\u20137.","journal-title":"Nature"},{"key":"1240_CR13","doi-asserted-by":"publisher","first-page":"1489438","DOI":"10.3389\/fcvm.2024.1489438","volume":"11","author":"H Zhang","year":"2024","unstructured":"Zhang H, Zhao J, Yu J, Zhang X, Ran S, Wang S, et al. Lactate metabolism and lactylation in cardiovascular disease: novel mechanisms and therapeutic targets. Front Cardiovasc Med. 2024;11:1489438.","journal-title":"Front Cardiovasc Med"},{"issue":"11","key":"1240_CR14","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/s42255-020-00288-1","volume":"2","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Taufalele PV, Cochran JD, Robillard-Frayne I, Marx JM, Soto J, et al. Mitochondrial pyruvate carriers are required for myocardial stress adaptation. Nat Metab. 2020;2(11):1248\u201364.","journal-title":"Nat Metab"},{"issue":"9","key":"1240_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108087","volume":"32","author":"C Dai","year":"2020","unstructured":"Dai C, Li Q, May HI, Li C, Zhang G, Sharma G, et al. Lactate dehydrogenase A governs cardiac hypertrophic growth in response to hemodynamic stress. Cell Rep. 2020;32(9):108087.","journal-title":"Cell Rep"},{"issue":"2","key":"1240_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.117163","volume":"319","author":"S Zhang","year":"2024","unstructured":"Zhang S, Liu Z, Zhang H, Zhou X, Wang X, Chen Y, et al. Effect and mechanism of Qing Gan Zi Shen decoction on heart damage induced by obesity and hypertension. J Ethnopharmacol. 2024;319(2):117163.","journal-title":"J Ethnopharmacol"},{"key":"1240_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.113833","volume":"271","author":"XY Chen","year":"2021","unstructured":"Chen XY, Chen XH, Li L, Su CP, Zhang YL, Jiang YY, et al. Deciphering the effective combinatorial components from Si-miao-yong-an decoction regarding the intervention on myocardial hypertrophy. J Ethnopharmacol. 2021;271:113833.","journal-title":"J Ethnopharmacol"},{"issue":"34","key":"1240_CR18","first-page":"5125","volume":"23","author":"W Chen","year":"2017","unstructured":"Chen W, Chen G. Danshen (Salvia miltiorrhiza Bunge): a prospective healing sage for cardiovascular diseases. Curr Pharm Des. 2017;23(34):5125\u201335.","journal-title":"Curr Pharm Des"},{"issue":"3","key":"1240_CR19","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.bbrc.2014.01.045","volume":"444","author":"M Liu","year":"2014","unstructured":"Liu M, Ye J, Gao S, Fang W, Li H, Geng B, et al. Salvianolic acid B protects cardiomyocytes from angiotensin II-induced hypertrophy via inhibition of PARP-1. Biochem Biophys Res Commun. 2014;444(3):346\u201353.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"1240_CR20","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3109\/13880209.2015.1029052","volume":"54","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Chen L, Li F, Wang H, Yao Y, Shu J, et al. Cryptotanshinone protects against adriamycin-induced mitochondrial dysfunction in cardiomyocytes. Pharm Biol. 2016;54(2):237\u201342.","journal-title":"Pharm Biol"},{"issue":"7","key":"1240_CR21","first-page":"841","volume":"27","author":"N Atefipour","year":"2024","unstructured":"Atefipour N, Dianat M, Badavi M, Radan M, Mard SA. Rosmarinic acid ameliorates the complications of monocrotaline-induced right ventricular hypertrophy on the left ventricle: investigating the signaling pathway of Wnt\/\u03b2-catenin in the heart. Iran J Basic Med Sci. 2024;27(7):841\u20139.","journal-title":"Iran J Basic Med Sci"},{"key":"1240_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2025.117309","volume":"498","author":"S Li","year":"2025","unstructured":"Li S, He P, Liu J, Zang S, Luo J, Luo Y, et al. Ferulic acid protects against stress-induced myocardial injury in mice. Toxicol Appl Pharmacol. 2025;498:117309.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"1240_CR23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3892\/etm.2014.1690","volume":"8","author":"Q Lu","year":"2014","unstructured":"Lu Q, Luo S, Wen Y. Effect of ligustilide on Ang II-induced hypertrophy in cardiomyocytes and the potential mechanisms. Exp Ther Med. 2014;8(1):169\u201374.","journal-title":"Exp Ther Med"},{"issue":"6","key":"1240_CR24","doi-asserted-by":"publisher","first-page":"453","DOI":"10.14740\/cr1583","volume":"14","author":"B Xiao","year":"2023","unstructured":"Xiao B, Zhao Y, Wang KK, Yang XC, Hu HJ, Li Y, et al. Inhibition of the STIM1\/Orai1 signaling pathway by glycine betaine mitigates myocardial hypertrophy in spontaneous hypertension rats. Cardiol Res. 2023;14(6):453\u201363.","journal-title":"Cardiol Res"},{"issue":"1","key":"1240_CR25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1159\/000527201","volume":"108","author":"XB Li","year":"2023","unstructured":"Li XB, Rekep M, Tian JH, Wu Q, Chen M, Yang S, et al. Luteolin attenuates diabetic myocardial hypertrophy by inhibiting proteasome activity. Pharmacol. 2023;108(1):47\u201360.","journal-title":"Pharmacol"},{"issue":"1","key":"1240_CR26","doi-asserted-by":"publisher","first-page":"26925","DOI":"10.1038\/s41598-025-12222-0","volume":"15","author":"SH Kim","year":"2025","unstructured":"Kim SH, Kee HJ, Zhou H, Park H, Lee SH, Sim DS, et al. Chlorogenic acid attenuates cardiac hypertrophy and fibrosis by downregulating galectin 3. Sci Rep. 2025;15(1):26925.","journal-title":"Sci Rep"},{"issue":"4","key":"1240_CR27","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.joim.2024.05.002","volume":"22","author":"J Xie","year":"2024","unstructured":"Xie J, Ma YL, Gui MT, Yao L, Li JH, Wang MZ, et al. Efficacy of Huoxue Qianyang Qutan recipe on essential hypertension: a randomized, double-blind, placebo-controlled trial. J Integr Med. 2024;22(4):484\u201392.","journal-title":"J Integr Med"},{"issue":"12","key":"1240_CR28","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20192909","volume":"39","author":"J Wang","year":"2019","unstructured":"Wang J, Dong ZH, Gui MT, Yao L, Li JH, Zhou XJ, et al. HuoXue QianYang quTan recipe attenuates left ventricular hypertrophy in obese hypertensive rats by improving mitochondrial function through SIRT1\/PGC-1\u03b1 deacetylation pathway. Biosci Rep. 2019;39(12):BSR20192909.","journal-title":"Biosci Rep"},{"issue":"4","key":"1240_CR29","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1038\/s41418-020-00729-0","volume":"28","author":"M Fernandez-Caggiano","year":"2021","unstructured":"Fernandez-Caggiano M, Eaton P. Heart failure-emerging roles for the mitochondrial pyruvate carrier. Cell Death Differ. 2021;28(4):1149\u201358.","journal-title":"Cell Death Differ"},{"issue":"5","key":"1240_CR30","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/s41419-018-0494-0","volume":"9","author":"D Li","year":"2018","unstructured":"Li D, Wang C, Ma P, Yu Q, Gu M, Dong L, et al. PGC1\u03b1 promotes cholangiocarcinoma metastasis by upregulating PDHA1 and MPC1 expression to reverse the Warburg effect. Cell Death Dis. 2018;9(5):466.","journal-title":"Cell Death Dis"},{"issue":"1","key":"1240_CR31","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12933-024-02178-2","volume":"23","author":"XM Ma","year":"2024","unstructured":"Ma XM, Geng K, Wang P, Jiang Z, Law BY, Xu Y. MCT4-dependent lactate transport: a novel mechanism for cardiac energy metabolism injury and inflammation in type 2 diabetes mellitus. Cardiovasc Diabetol. 2024;23(1):96.","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"1240_CR32","first-page":"R382","volume":"276","author":"BE Levin","year":"1999","unstructured":"Levin BE. Arcuate NPY neurons and energy homeostasis in diet-induced obese and resistant rats. Am J Physiol. 1999;276(2):R382\u20137.","journal-title":"Am J Physiol"},{"key":"1240_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.155957","volume":"158","author":"W Zhu","year":"2024","unstructured":"Zhu W, Guo S, Sun J, Zhao Y, Liu C. Lactate and lactylation in cardiovascular diseases: current progress and future perspectives. Metabolism. 2024;158:155957.","journal-title":"Metabolism"},{"issue":"3","key":"1240_CR34","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.cmet.2020.12.003","volume":"33","author":"AA Cluntun","year":"2021","unstructured":"Cluntun AA, Badolia R, Lettlova S, Parnell KM, Shankar TS, Diakos NA, et al. The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure. Cell Metab. 2021;33(3):629\u201348.","journal-title":"Cell Metab"},{"issue":"4","key":"1240_CR35","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.18632\/aging.102818","volume":"12","author":"A Gizak","year":"2020","unstructured":"Gizak A, McCubrey JA, Rakus D. Cell-to-cell lactate shuttle operates in heart and is important in age-related heart failure. Aging (Albany NY). 2020;12(4):3388\u2013406.","journal-title":"Aging (Albany NY)"},{"issue":"16","key":"1240_CR36","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70022","volume":"28","author":"SS Zhao","year":"2024","unstructured":"Zhao SS, Liu J, Wu QC, Zhou XL. Lactate regulates pathological cardiac hypertrophy via histone lactylation modification. J Cell Mol Med. 2024;28(16):e70022.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"1240_CR37","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13578-023-01098-0","volume":"13","author":"T Wei","year":"2023","unstructured":"Wei T, Guo Y, Huang C, Sun M, Zhou B, Gao J, et al. Fibroblast-to-cardiomyocyte lactate shuttle modulates hypertensive cardiac remodelling. Cell Biosci. 2023;13(1):151.","journal-title":"Cell Biosci"},{"issue":"4","key":"1240_CR38","doi-asserted-by":"publisher","DOI":"10.1111\/apha.14016","volume":"238","author":"S Tavoulari","year":"2023","unstructured":"Tavoulari S, Sichrovsky M, Kunji ERS. Fifty years of the mitochondrial pyruvate carrier: new insights into its structure, function, and inhibition. Acta Physiol (Oxf). 2023;238(4):e14016.","journal-title":"Acta Physiol (Oxf)"},{"issue":"6090","key":"1240_CR39","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1126\/science.1218099","volume":"337","author":"DK Bricker","year":"2012","unstructured":"Bricker DK, Taylor EB, Schell JC, Orsak T, Boutron A, Chen YC, et al. A mitochondrial pyruvate carrier required for pyruvate uptake in yeast, Drosophila, and humans. Science. 2012;337(6090):96\u2013100.","journal-title":"Science"},{"issue":"11","key":"1240_CR40","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1038\/s42255-020-00296-1","volume":"2","author":"KS McCommis","year":"2020","unstructured":"McCommis KS, Kovacs A, Weinheimer CJ, Shew TM, Koves TR, Ilkayeva OR, et al. Nutritional modulation of heart failure in mitochondrial pyruvate carrier-deficient mice. Nat Metab. 2020;2(11):1232\u201347.","journal-title":"Nat Metab"},{"issue":"11","key":"1240_CR41","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/s42255-020-00276-5","volume":"2","author":"M Fernandez-Caggiano","year":"2020","unstructured":"Fernandez-Caggiano M, Kamynina A, Francois AA, Prysyazhna O, Eykyn TR, Krasemann S, et al. Mitochondrial pyruvate carrier abundance mediates pathological cardiac hypertrophy. Nat Metab. 2020;2(11):1223\u201331.","journal-title":"Nat Metab"},{"issue":"3","key":"1240_CR42","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1159\/000354470","volume":"32","author":"Y Zhu","year":"2013","unstructured":"Zhu Y, Wu J, Yuan SY. MCT1 and MCT4 expression during myocardial ischemic-reperfusion injury in the isolated rat heart. Cell Physiol Biochem. 2013;32(3):663\u201374.","journal-title":"Cell Physiol Biochem"},{"issue":"11","key":"1240_CR43","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431x20187660","volume":"51","author":"D Gabriel-Costa","year":"2018","unstructured":"Gabriel-Costa D, Cunha TF, Paix\u00e3o NA, Fortunato RS, Rego-Monteiro ICC, Barreto-Chaves MLM, et al. Lactate-upregulation of lactate oxidation complex-related genes is blunted in left ventricle of myocardial infarcted rats. Braz J Med Biol Res. 2018;51(11):e7660.","journal-title":"Braz J Med Biol Res"},{"key":"1240_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.cophys.2022.100489","volume":"25","author":"MP Lazaropoulos","year":"2022","unstructured":"Lazaropoulos MP, Elrod JW. Mitochondria in pathological cardiac remodeling. Curr Opin Physiol. 2022;25:100489.","journal-title":"Curr Opin Physiol"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-025-01240-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-025-01240-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-025-01240-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T11:04:18Z","timestamp":1761217458000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmjournal.biomedcentral.com\/articles\/10.1186\/s13020-025-01240-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1240"],"URL":"https:\/\/doi.org\/10.1186\/s13020-025-01240-9","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,23]]},"assertion":[{"value":"11 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experimental protocol involving animals received full ethical approval from the Institutional Animal Care and Use Committee of Shanghai University of TCM (Approval No. PZSHUTCM2404280007).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to publish this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"180"}}